MedPath

Chronic Kidney Disease - REAL Life Study in Alsace

Recruiting
Conditions
Chronic Kidney Diseases
Registration Number
NCT05527626
Lead Sponsor
University Hospital, Strasbourg, France
Brief Summary

Chronic kidney disease (CKD) is a public health problem and affects about 10% of the world's adult population with a constantly increasing incidence. The approach to CKD in France is centered on access to replacement therapy (dialysis, renal transplantation), the cost of which amounts to 4 billion euros (data from the REIN registry).

Real-life data are essential to specify the characteristics of patients with chronic kidney disease and the factors associated with the evolution of CKD and the occurrence of complications in order to improve the management of CKD before the suppletion stage.

Since October 2019, CKD at the severe stage (stage 4) and at the non-dialysis end stage (stage 5) is subject to an annual flat fee (Article L. 162-22-6-2 of the Social Security Code). The reimbursement of these lump sums by the health insurance is subject to the collection and transmission of certain medical data by the establishments.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
3000
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Retroanalysis of the risk factors in patients with severe chronic kidney diseaseFiles analysed retrospectively from October 01, 2019 to February 31, 2027 will be examined

Analysis of risk factors in patients with severe chronic kidney disease by retrospectively analyzing health data contained in patient medical records

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Service Néphrologie-Dialyse-Transplantation - CHU de Strasbourg - France

🇫🇷

Strasbourg, France

© Copyright 2025. All Rights Reserved by MedPath